Date: 1.10.2021
Summary:
A Danish biotechnology SME is developing a novel software for recombinant antibody-developers, giving them an easy-to-use tool to predict which antibodies are most likely to succeed during production. In the collaboration proposed, the partner will have free access to the solution during the closed beta in return for feedback on the use and performance. The company offers technical cooperation and commercial agreements with technical assistance.
Reference: TODK20210722001
Country: Denmark
Submitted: 1. 10. 2021
Keywords
Technology: Artificial Intelligence (AI), Data Processing / Data Interchange, Middleware, Medical Technology / Biomedical Engineering, Biochemistry / Biophysics, Protein Engineering.
Market: Monoclonal Antibodies and Hybridomas, Biochemistry / Biophysics, Enzymology/Protein Engineering/Fermentation.
NACE: -
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology events no 8 - Page 8 of our database of biotechnology events
Science Magazine
Meet pAblo·pCasso: A new leap in CRISPR technologies for next-gen genome engineering
New possibilities for the medical use of botulinun toxin A1